Indictment of James Shortt, M.D.
In November 2005, James Michael Shortt, M.D., who practiced "longevity medicine" in Greenville, South Carolina, was charged with 43 counts of improperly distributing growth hormones and other steroid drugs. Some counts state that he distributed steroid drugs "not for a legitimate purpose" and "outside the usual course of professional practice." Other counts stated that he dispensed human growth hormone "for "a use . . . other than the treatment of a disease or other recognized medical condition." Press reports indicate that some of the recipients were professional football players. In March 2006, Shortt pleaded guilty to one count of conspiracy to distribute anabolic steroids and human growth hormone. Based on this admission, the South Carolina Board revoked his license and fined him $10,000, the largest fine it is permitted to impose. Shortt is also being sued by the survivors of two patients he treated with hydrogen peroxide. One had multiple sclerosis. The other had prostate cancer.
IN THE COURT OF THE UNITED STATES
DISTRICT OF SOUTH CAROLINA
COLUMBIA DIVISION
UNITED STATES OF AMERICA v. JAMES M. SHORTT |
) |
CRIMINAL NO. 21 U.S.C. § 846 |
SUPERSEDING INDICTMENT
COUNT 1
THE GRAND JURY CHARGES:
That beginning at a time unknown to the Grand Jury, but beginning at least in or around December 1998, and continuingthrough on or about September 21, 2005, in the District of South Carolina, and elsewhere, the defendant, JAMES M. SHORTT, knowingly and intentionally did conspire with others, both known and unknown to the grand jury, to knowingly, intentionally, and unlawfully possess with intent to distribute and dispense, to distribute and dispense, and to cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroids testosterone, stanozolol, nandrolone, fluoxymesterone, and oxymetholone, Schedule III controlled substances, in violation of Title 21, United States Code, Section 841(a)(1), and human growth hormone, in violation of Title 21, United States Code, Section 333(e);
All in violation of Title 21, United States Code, Section 846.
COUNT 2
THE GRAND JURY FURTHER CHARGES:
That on or about February 7, 2001, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 3
THE GRAND JURY FURTHER CHARGES:
That on or about March 14, 2001, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 4
THE GRAND JURY FURTHER CHARGES:
That on or about April 10, 2001, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 5
THE GRAND JURY FURTHER CHARGES:
That on or about April 16, 2001, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 6
THE GRAND JURY FURTHER CHARGES:
That on or about June 14, 2001, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 7
THE GRAND JURY FURTHER CHARGES:
That on or about July 24, 2001, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 8
THE GRAND JURY FURTHER CHARGES:
That on or about March 5, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 9
THE GRAND JURY FURTHER CHARGES:
That on or about April 18, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 10
THE GRAND JURY FURTHER CHARGES:
That on or about May 1, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 11
THE GRAND JURY FURTHER CHARGES:
That on or about May 14, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 12
THE GRAND JURY FURTHER CHARGES:
That on or about July 8, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 13
THE GRAND JURY FURTHER CHARGES:
That on or about July 31, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 14
THE GRAND JURY FURTHER CHARGES:
That on or about September 18, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 15
THE GRAND JURY FURTHER CHARGES:
That on or about December 19, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid nandrolone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 16
THE GRAND JURY FURTHER CHARGES:
That on or about December 19, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 17
THE GRAND JURY FURTHER CHARGES:
That on or about January 29, 2003, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 18
THE GRAND JURY FURTHER CHARGES:
That on or about March 3, 2003, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 19
THE GRAND JURY FURTHER CHARGES:
That on or about May 6, 2003, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 20
THE GRAND JURY FURTHER CHARGES:
That on or about May 21, 2003, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 21
THE GRAND JURY FURTHER CHARGES:
That on or about October 21, 2003, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 22
THE GRAND JURY FURTHER CHARGES:
That on or about December 16, 2003, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 23
THE GRAND JURY FURTHER CHARGES:
That on or about January 20, 2004, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroids testosterone and stanozolol, Schedule III controlled substances; In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 24
THE GRAND JURY FURTHER CHARGES:
That on or about January 23, 2004, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 25
THE GRAND JURY FURTHER CHARGES:
That on or about March 10, 2004, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 26
THE GRAND JURY FURTHER CHARGES:
That on or about March 16, 2004, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 27
THE GRAND JURY FURTHER CHARGES:
That on or about June 1, 2004, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 28
THE GRAND JURY FURTHER CHARGES:
That on or about June 1, 2004, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid testosterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 29
THE GRAND JURY FURTHER CHARGES:
That on or about February 18, 2003, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, human growth hormone, that is, Somatropin, for a use in humans other than where such use had been authorized by the Secretary of Health and Human Services and pursuant to the order of a physician,
In violation of Title 21, United States Code, Section 333(e)(1), and Title 18, United States Code, Section 2.
COUNT 30
THE GRAND JURY FURTHER CHARGES:
That on or about February 21, 2001, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid fluoxymesterone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 31
THE GRAND JURY FURTHER CHARGES:
That on or about April 10, 2001, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid oxymetholone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 32
THE GRAND JURY FURTHER CHARGES:
That on or about May 14, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, not for a legitimate medical purpose and outside the usual course of professional practice, the anabolic steroid oxymetholone, a Schedule III controlled substance;
In violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(D), and Title 18, United States Code, Section 2.
COUNT 33
THE GRAND JURY FURTHER CHARGES:
That on or about January 16, 2001, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, human growth hormone, for a use in humans other than where such use had been authorized by the Secretary of Health and Human Services and pursuant to the order of a physician,
In violation of Title 21, United States Code, Section 333(e)(1), and Title 18, United States Code, Section 2.
COUNT 34
THE GRAND JURY FURTHER CHARGES:
That on or about July 22, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, human growth hormone, for a use in humans other than where such use had been authorized by the Secretary of Health and Human Services and pursuant to the order of a physician,
In violation of Title 21, United States Code, Section 333(e)(1), and Title 18, United States Code, Section 2.
COUNT 35
THE GRAND JURY FURTHER CHARGES:
That on or about July 31, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, human growth hormone, for a use in humans other than where such use had been authorized by the Secretary of Health and Human Services and pursuant to the order of a physician,
In violation of Title 21, United States Code, Section 333(e)(1), and Title 18, United States Code, Section 2.
COUNT 36
THE GRAND JURY FURTHER CHARGES:
That on or about October 3, 2002, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, human growth hormone, for a use in humans other than where such use had been authorized by the Secretary of Health and Human Services and pursuant to the order of a physician,
In violation of Title 21, United States Code, Section 333(e)(1), and Title 18, United States Code, Section 2.
COUNT 37
THE GRAND JURY FURTHER CHARGES:
That on or about March 1, 2003, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, human growth hormone, for a use in humans other than where such use had been authorized by the Secretary of Health and Human Services and pursuant to the order of a physician,
In violation of Title 21, United States Code, Section 333(e)(1), and Title 18, United States Code, Section 2.
COUNT 38
THE GRAND JURY FURTHER CHARGES:
That on or about April 9, 2003, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, human growth hormone, for a use in humans other than where such use had been authorized by the Secretary of Health and Human Services and pursuant to the order of a physician,
In violation of Title 21, United States Code, Section 333(e)(1), and Title 18, United States Code, Section 2.
COUNT 39
THE GRAND JURY FURTHER CHARGES:
That on or about July 10, 2003, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, human growth hormone, for a use in humans other than where such use had been authorized by the Secretary of Health and Human Services and pursuant to the order of a physician,
In violation of Title 21, United States Code, Section 333(e)(1), and Title 18, United States Code, Section 2.
COUNT 40
THE GRAND JURY FURTHER CHARGES:
That on or about August 19, 2003, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, human growth hormone, for a use in humans other than where such use had been authorized by the Secretary of Health and Human Services and pursuant to the order of a physician,
In violation of Title 21, United States Code, Section 333(e)(1), and Title 18, United States Code, Section 2.
COUNT 41
THE GRAND JURY FURTHER CHARGES:
That on or about September 9, 2003, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, human growth hormone, for a use in humans other than where such use had been authorized by the Secretary of Health and Human Services and pursuant to the order of a physician,
In violation of Title 21, United States Code, Section 333(e)(1), and Title 18, United States Code, Section 2.
COUNT 42
THE GRAND JURY FURTHER CHARGES:
That on or about February 19, 2004, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, human growth hormone, for a use in humans other than where such use had been authorized by the Secretary of Health and Human Services and pursuant to the order of a physician,
In violation of Title 21, United States Code, Section 333(e)(1), and Title 18, United States Code, Section 2.
COUNT 43
THE GRAND JURY FURTHER CHARGES:
That on or about April 2, 2004, in the District of South Carolina, the defendant, JAMES M. SHORTT, knowingly, intentionally, and unlawfully did possess with intent to distribute and dispense; did distribute and dispense; and did cause to be distributed and dispensed, human growth hormone, for a use in humans other than where such use had been authorized by the Secretary of Health and Human Services and pursuant to the order of a physician,
In violation of Title 21, United States Code, Section 333(e)(1), and Title 18, United States Code, Section 2.
A TRUE BILL
_____________________________
FOREPERSON
JONATHAN S. GASSER (WDHjr)
ACTING UNITED STATES ATTORNEY
This page was revised on June 9, 2006.